We are live on ! Find out more
HSTO

Histogen Inc. Common Stock
HSTO

Delisted

HSTO was delisted on the 4th of October, 2023.

Back to rankings

10 hedge funds and large institutions have $229K invested in Histogen Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

55% less funds holding

Funds holding: 22 → 10 (-12)

77% less capital invested

Capital invested by funds: $1M → $229K (-$772K)

80% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 15

Holders
10
Holders Change
-12
Holders Change %
-54.55%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
3
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Prudential Financial
Prudential Financial
New Jersey
+$46.7K
2
HF
HRT Financial
New York
+$40.8K
3
Citadel Advisors
Citadel Advisors
Florida
+$37.9K
4
JP Morgan Chase
JP Morgan Chase
New York
+$19.4K
5
Wells Fargo
Wells Fargo
California
+$4

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$292K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$126K
3
State Street
State Street
Massachusetts
-$43K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$39K
5
Millennium Management
Millennium Management
New York
-$24K

HSTO Hedge Fund Activity: Q2 2022 in Review

10 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q2 2022, worth a combined $229K — down 77% from $1M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of HSTO and 3 opened new positions — a net loss of 12 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Prudential Financial, opening a new position worth an estimated $46.7K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $292K sold.

  • 10 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q2 2022, down from 22 in Q1 2022.
  • Funds reported $229K of Histogen Inc. Common Stock stock for Q2 2022, down 77% quarter-over-quarter.
  • 3 funds opened new Histogen Inc. Common Stock positions in Q2 2022 and 15 closed out, a net change of -12 holders.
  • The largest Histogen Inc. Common Stock buyer in Q2 2022 was Prudential Financial, an estimated $46.7K added.
  • The largest Histogen Inc. Common Stock seller in Q2 2022 was Renaissance Technologies, an estimated $292K sold.

Based on aggregated 13F filings for Q2 2022.